We are live on ! Find out more
LUCD icon

Lucid Diagnostics
LUCD

18 hedge funds and large institutions have $2.59M invested in Lucid Diagnostics in 2023 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 5 increasing their positions, 4 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

25% more repeat investments, than reductions

Existing positions increased: 5 | Existing positions reduced: 4

4% more capital invested

Capital invested by funds: $2.49M → $2.59M (+$104K)

0.19% more ownership

Funds ownership: 4.08% → 4.26% (+0.19%)

5% less funds holding

Funds holding: 19 → 18 (-1)

33% less first-time investments, than exits

New positions opened: 2 | Existing positions closed: 3

Holders
18
Holders Change
-1
Holders Change %
-5.26%
% of All Funds
0.28%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
5
Reduced
4
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Geode Capital Management
Geode Capital Management
Massachusetts
+$154K
2
Citadel Advisors
Citadel Advisors
Florida
+$94.2K
3
LM
Luminus Management
Texas
+$34.8K
4
BlackRock
BlackRock
New York
+$11.2K
5
Vanguard Group
Vanguard Group
Pennsylvania
+$603

Top Sellers

Rank Fund Capital Flow
1
NCM
Nantahala Capital Management
Connecticut
-$94.3K
2
VF
Virtu Financial
New York
-$22K
3
Verition Fund Management
Verition Fund Management
Connecticut
-$21.5K
4
TRCT
Tower Research Capital (TRC)
New York
-$4.62K
5
UBS Group
UBS Group
Switzerland
-$3.58K
Name Holding Trade Value Shares
Change 		Change in
Stake
LM
1
Luminus Management
Texas
$1.22M +$34.8K +23,078 +3%
Vanguard Group
2
Vanguard Group
Pennsylvania
$445K +$603 +400 +0.1%
NCM
3
Nantahala Capital Management
Connecticut
$277K -$94.3K -62,590 -24%
Geode Capital Management
4
Geode Capital Management
Massachusetts
$199K +$154K +101,922 +245%
BCM
5
Bridgeway Capital Management
Texas
$188K – – –
Citadel Advisors
6
Citadel Advisors
Florida
$86.9K +$94.2K +62,511 New
Verition Fund Management
7
Verition Fund Management
Connecticut
$50.3K -$21.5K -14,296 -28%
GWM
8
Geneos Wealth Management
Colorado
$47.1K – – –
BlackRock
9
BlackRock
New York
$36.6K +$11.2K +7,448 +39%
LPL Financial
10
LPL Financial
California
$20K – – –
State Street
11
State Street
Massachusetts
$14.6K – – –
Carson Wealth (CWM LLC)
12
Carson Wealth (CWM LLC)
Nebraska
$3K – – –
Osaic Holdings
13
Osaic Holdings
Arizona
$2.78K – – –
Morgan Stanley
14
Morgan Stanley
New York
$278 -$904 -600 -75%
Wells Fargo
15
Wells Fargo
California
$131 +$53 +35 +59%
TRCT
16
Tower Research Capital (TRC)
New York
$38 -$4.62K -3,066 -99%
VF
17
Virtu Financial
New York
– -$22K -15,545 Closed
UBS Group
18
UBS Group
Switzerland
– -$3.58K -2,558 Closed
BAM
19
Belpointe Asset Management
Nevada
– -$2.1K -1,500 Closed
Royal Bank of Canada
20
Royal Bank of Canada
Ontario, Canada
– +$143 +95 New

LUCD Hedge Fund Activity: Q2 2023 in Review

18 of the 6,369 institutional investors tracked by Wall St. Rank reported a position in Lucid Diagnostics (LUCD) for Q2 2023, worth a combined $2.59M — up 4.2% from $2.49M a quarter earlier.

Sellers outnumbered buyers: 3 funds closed out of LUCD and 2 opened new positions — a net loss of 1 holder — while 4 trimmed existing stakes and 5 added.

The largest buyer was Geode Capital Management, adding an estimated $154K. The largest seller was Nantahala Capital Management, cutting an estimated $94.3K.

  • 18 institutional investors held Lucid Diagnostics (LUCD) as of Q2 2023, down from 19 in Q1 2023.
  • Funds reported $2.59M of Lucid Diagnostics stock for Q2 2023, up 4.2% quarter-over-quarter.
  • 2 funds opened new Lucid Diagnostics positions in Q2 2023 and 3 closed out, a net change of -1 holder.
  • The largest Lucid Diagnostics buyer in Q2 2023 was Geode Capital Management, an estimated $154K added.
  • The largest Lucid Diagnostics seller in Q2 2023 was Nantahala Capital Management, an estimated $94.3K sold.

Based on aggregated 13F filings for Q2 2023.